Clinical relevance of Mycobacterium malmoense isolation in the Netherlands

Hoefsloot W., van Ingen J., de Lange W. C. M., Dekhuijzen P. N. R., Boeree M. J., van Soolingen D.

Source: Eur Respir J 2009; 34: 926-931
Journal Issue: October
Disease area: Respiratory infections

Congress or journal article abstractFull text journal articlePDF journal article, handout or slides

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
Hoefsloot W., van Ingen J., de Lange W. C. M., Dekhuijzen P. N. R., Boeree M. J., van Soolingen D.. Clinical relevance of Mycobacterium malmoense isolation in the Netherlands. Eur Respir J 2009; 34: 926-931

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Pulmonary diseases caused by non-tuberculous mycobacteria
Source: Eur Respir Mon 2012; 58: 25-37
Year: 2012


The spectrum of drug susceptibility of slow-growing nontuberculous mycobacteria (MAC, M. kansasii, M. xenopi)
Source: International Congress 2017 – Clinical challenges in chronic lung diseases
Year: 2017

Nontuberculous mycobacterial infections
Source: Eur Respir Mon 2011; 52: 115-129
Year: 2011


Clinical and laboratory features of Mycobacterium avium complex infection in comparison with infection, caused by Mycobacterium tuberculosis, in HIV-infected patients
Source: International Congress 2019 – Tuberculosis and non-TB mycobacterial infection II
Year: 2019


Invasive Mycobacterium avium intracellulare infection
Source: Eur Respir J 2006; 28: Suppl. 50, 312s
Year: 2006

Recurrent laboratory pseudo-outbreaks of Mycobacterium intracellulare
Source: Annual Congress 2008 - Aetiology of respiratory infections: mycobacteria and fungi
Year: 2008

Clinical relevance of differentiation between Mycobacterium avium and M. intracellulare in M. avium complex pulmonary disease in Croatia
Source: International Congress 2019 – Extra-pulmonary tuberculosis and comorbidities
Year: 2019


Atypical manifestations of mycobacterium tuberculosis infection
Source: Eur Respir J 2004; 24: Suppl. 48, 647s
Year: 2004

Identification of nontuberculous mycobacteria using GenoType® Mycobacterium CM
Source: Annual Congress 2010 - Nontuberculous mycobacterial infections and tuberculosis
Year: 2010


The first case of mycobacterium shimoidei infection in the UK
Source: Annual Congress 2011 - Clinical challenges in tuberculosis
Year: 2011

On the nature of Mycobacterium tuberculosis-latent bacilli
Source: Eur Respir J 2004; 24: 1044-1051
Year: 2004



Inhaled therapies, azithromycin and Mycobacterium abscessus in cystic fibrosis patients
Source: Eur Respir J 2013; 41: 1101-1106
Year: 2013



Pulmonary mycobacterium xenopi infection in Japan
Source: International Congress 2015 – Non-tuberculous mycobacteria and molecular microbiology
Year: 2015


Mycobacterium xenopi pulmonary disease in Croatia
Source: International Congress 2017 – Microbiology and laboratory techniques to monitor NTM infections
Year: 2017


Clinical analysis of pulmonary Mycobacterium kansasii disease
Source: International Congress 2018 – Difficult-to-treat respiratory infections
Year: 2018

Susceptibility to nontuberculous mycobacterial lung disease
Source: Eur Respir J 2008; 31: 1322-1333
Year: 2008



Isolation of mycobacterium tuberculosis and mycobacterium africanum from HIV/AIDS patients with pulmonary tuberculosis in Ibadan, Nigeria
Source: Annual Congress 2007 - Research perspectives: diagnosis and treatment of tuberculosis
Year: 2007


Management of Mycobacterium avium complex and Mycobacterium abscessus pulmonary disease: therapeutic advances and emerging treatments
Source: Eur Respir Rev, 31 (163) 210212; 10.1183/16000617.0212-2021
Year: 2022



Clinical features of radiologically atypical Mycobacterium kansasii lung disease in Japan
Source: International Congress 2019 – Clinical investigations of non-TB mycobacterial infection
Year: 2019


Bedaquiline as a potential agent in the treatment of M. intracellulare and M. avium infections
Source: Eur Respir J , 49 (3) 1601969; DOI: 10.1183/13993003.01969-2016
Year: 2017